The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
A bioassay case study summarizing the challenges in setting the control system of a combination product of two highly similar monoclonal therapeutic antibodies targeting the same cellular antigen: from similar modes of action and synergistic effect to the control of each molecule bioactivity in vitro.